Overactivation of these pathways contributes to oxidative stress and endothelial dysfunction in hypertension, lipid imbalances in dyslipidemia, mitochondrial damage in chronic kidney disease and insulin signaling impairment in diabetes (Figure 1). This evidence concerns the gene INS and diabetes mellitus.